INVENTIVA Announces a U.S. Phase II Investigator-Initiated Study with Lanifibranor on Non-Alcoholic Fatty Liver Disease in Patients with Type 2 Diabetes

David Linetsky
Point-of-Care Marketing

Bud Bilanich
Success Coach

Daniel Sontupe
Market Access

Stacey Gandler
Brand Nourishment

Brenda Snow
Authentic Patient Voice

Joey Cohen
Medication Adherence

Pat Purcell
Meeting Engagement

Suma Ramadas, PhD
Medical Affairs

Matt Turner
Patient Affordability

Amy Giles
Increasing Engagement

Liz Kane
Impactful Strategy

Frank Burrell
Scientific Storytelling

Paul Theisen
Patient Acquisition

Matthew Durham
Omnidynamic Marketing